Who we are
Chieron has established a strong presence in specific therapeutic segments such as cardiovascular and central nervous system (CNS). The company aspires to maintain its market leadership in these areas by continuously adding new molecules and expanding its global footprint. VNAI’s strategy includes global filings and approvals for all its products, enabling the company to engage with key customers worldwide. This approach has helped the company build a sustainable business model with a well-organized production and inventory planning system
Chieron stands as a pioneer manufacturer of unique niche Active Pharmaceutical Ingredients (APIs), holding prestigious approvals, including six Certificates of Suitability (COS) Approval, USFDA, and Korean FDA Approvals. But our journey doesn’t end here; we are tirelessly pursuing approvals from ANVISA and the Chinese cFDA for our key products.
Established in the year 2007, our mission has always been clear: ‘Delivering Best Quality and Cost Leadership in the supply of Intermediates & APIs to customers globally while achieving the highest levels of customer satisfaction.’
Our strategic focus on Backward Integration not only ensures cost competitiveness but also guarantees supply reliability and impeccable quality control. We proudly serve as a Contract Development and Manufacturing Organization (CDMO/CMO) partner to esteemed clients across Europe, Japan, and the Korean Region and expanding our presence Globally.
Innovation is at our core, with world-class Research and Analytics Laboratories facilitating new product development, alongside a Pilot plant conveniently located on-site. Our Compliance trails show the strength about our quality systems.
Approved sites by
USFDA
EDQM
PMDA
KFDA
Leadership at Chieron
Mr. Chandra Kumar Verma serves as the CEO and Managing Director of CHIERON, steering the company within the dynamic pharmaceutical landscape with his extensive industry expertise. With a distinguished career marked by senior leadership roles at prominent pharmaceutical firms, Mr. Verma brings a depth of knowledge and experience to CHIERON, where he champions innovation, operational excellence, and sustainable growth.
As an inspiring leader, Mr. Verma fosters a collaborative environment that drives his team toward a shared vision of success. His strategic insights and quick decision-making abilities have earned him recognition, including the Chairman’s Excellence Award at Dr. Reddy’s in 2017.
Beyond his professional pursuits, Mr. Verma is passionate about travel and exploration. His commitment to personal and professional growth embodies his belief that discovery and learning are integral to achieving new heights in the pharmaceutical sector.